Merck takeover $1.75 a share, page-19

Woohoo... so glad it has now finally happened!

Despite my belief that VLA is worth far more than $1.75, and despite the fact that I didn't buy more at the low shareprice levels it got to in the last couple of months... I am ecstatic. Ecstatic that some of my dough will now safely be out of the stock market.

It is also sobering to know for certain that Cavatak is finally on its way to being a viable pharmaceutical drug that will benefit so many cancer sufferers.

Patience does pay off sometimes! In this case... definitely. High-five to all the optimistic, patient and informative posters here on HC.